VISIT OUR VIRTUAL BOOTH

• At uniQure, we are currently conducting an early phase clinical trial to investigate a new potential gene therapy for patients with Huntington’s disease.
• uniQure is leveraging more than 20 years of experience in gene therapy to develop treatments for rare genetic diseases including Huntington’s disease.

Read more about AMT-130

Visit us at:
https://www.ingeneuityhub.com/

Follow us:

1. Twitter: @uniQure_NV
2. LinkedIn: https://www.linkedin.com/company/uniqure